ECB-ART-43206
Antimicrob Agents Chemother
2014 Jan 01;584:1862-71. doi: 10.1128/AAC.00686-13.
Show Gene links
Show Anatomy links
Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.
Bastos MF
,
Albrecht L
,
Kozlowski EO
,
Lopes SC
,
Blanco YC
,
Carlos BC
,
Castiñeiras C
,
Vicente CP
,
Werneck CC
,
Wunderlich G
,
Ferreira MU
,
Marinho CR
,
Mourão PA
,
Pavão MS
,
Costa FT
.
Abstract
Sequestration of Plasmodium falciparum-infected erythrocytes (Pf-iEs) in the microvasculature of vital organs plays a key role in the pathogenesis of life-threatening malaria complications, such as cerebral malaria and malaria in pregnancy. This phenomenon is marked by the cytoadhesion of Pf-iEs to host receptors on the surfaces of endothelial cells, on noninfected erythrocytes, and in the placental trophoblast; therefore, these sites are potential targets for antiadhesion therapies. In this context, glycosaminoglycans (GAGs), including heparin, have shown the ability to inhibit Pf-iE cytoadherence and growth. Nevertheless, the use of heparin was discontinued due to serious side effects, such as bleeding. Other GAG-based therapies were hampered due to the potential risk of contamination with prions and viruses, as some GAGs are isolated from mammals. In this context, we investigated the effects and mechanism of action of fucosylated chondroitin sulfate (FucCS), a unique and highly sulfated GAG isolated from the sea cucumber, with respect to P. falciparum cytoadhesion and development. FucCS was effective in inhibiting the cytoadherence of Pf-iEs to human lung endothelial cells and placenta cryosections under static and flow conditions. Removal of the sulfated fucose branches of the FucCS structure virtually abolished the inhibitory effects of FucCS. Importantly, FucCS rapidly disrupted rosettes at high levels, and it was also able to block parasite development by interfering with merozoite invasion. Collectively, these findings highlight the potential of FucCS as a candidate for adjunct therapy against severe malaria.
PubMed ID: 24395239
PMC ID: PMC4023758
Article link: Antimicrob Agents Chemother
Genes referenced: LOC100887844
References [+] :
,
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.
2000, Pubmed
, Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. 2000, Pubmed
, Severe and complicated malaria. World Health Organization Malaria Action Programme. 1986, Pubmed
al-Yaman, Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity. 1995, Pubmed
Andrews, Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharides. 2005, Pubmed
Avril, Placenta cryosections for study of the adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A in flow conditions. 2004, Pubmed
Barragan, Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. 1999, Pubmed
Beeson, Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta. 2002, Pubmed
Beeson, Parasite adhesion and immune evasion in placental malaria. 2001, Pubmed
Berendt, Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. 1989, Pubmed
Borsig, Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitment. 2007, Pubmed , Echinobase
Boyle, Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. 2010, Pubmed
Bray, The sequestration of Plasmodium falciparum infected erythrocytes in the placenta. 1979, Pubmed
Butcher, Inhibition of growth in vitro of Plasmodium falciparum by complex polysaccharides. 1988, Pubmed
Carlson, Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. 1994, Pubmed
Carlson, Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. 1990, Pubmed
Carlson, Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions. 1992, Pubmed
Carvalho, On the cytoadhesion of Plasmodium vivax-infected erythrocytes. 2010, Pubmed
Chen, Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. 1998, Pubmed
Clark, Saccharide anions as inhibitors of the malaria parasite. 1997, Pubmed
Clark, The cytokine theory of human cerebral malaria. 1994, Pubmed
Clark, Role of TNF in cerebral malaria. 1991, Pubmed
Costa, Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites. 2003, Pubmed
Dellicour, Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. 2010, Pubmed
Dondorp, Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. 2005, Pubmed
Doumbo, High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. 2009, Pubmed
Duffy, Malaria in the pregnant woman. 2005, Pubmed
Evans, The effect of curdlan sulphate on development in vitro of Plasmodium falciparum. 1998, Pubmed
Fernandez, Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria. 1998, Pubmed
Fievet, Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta. 2001, Pubmed
Fonseca, Fucosylated chondroitin sulfate as a new oral antithrombotic agent. 2006, Pubmed , Echinobase
Fried, Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. 1998, Pubmed
Fried, Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. 2006, Pubmed
Fried, Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. 1996, Pubmed
Gay, Isolation and characterization of brain microvascular endothelial cells from Saimiri monkeys. An in vitro model for sequestration of Plasmodium falciparum-infected erythrocytes. 1995, Pubmed
Glauser, Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate. 2008, Pubmed , Echinobase
Handunnetti, Uninfected erythrocytes form "rosettes" around Plasmodium falciparum infected erythrocytes. 1989, Pubmed
Hanson, Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. 2012, Pubmed
Hasler, An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1. 1993, Pubmed
Havlik, The effect of curdlan sulphate on in vitro growth of Plasmodium falciparum. 1994, Pubmed
Jaroonvesama, Intravascular coagulation in falciparum malaria. 1972, Pubmed
John, Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. 2010, Pubmed
Juillerat, Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition. 2011, Pubmed
Kulane, Effect of different fractions of heparin on Plasmodium falciparum merozoite invasion of red blood cells in vitro. 1992, Pubmed
Kyriacou, In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate. 2007, Pubmed
Lekana Douki, Sequestration of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A, a receptor for maternal malaria: monoclonal antibodies against the native parasite ligand reveal pan-reactive epitopes in placental isolates. 2002, Pubmed
Luse, Plasmodium falciparum malaria. Ultrastructure of parasitized erythrocytes in cardiac vessels. 1971, Pubmed
MacPherson, Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. 1985, Pubmed
Menendez, Malaria during pregnancy. 2006, Pubmed
Miller, Distribution of mature trophozoites and schizonts of Plasmodium falciparum in the organs of Aotus trivirgatus, the night monkey. 1969, Pubmed
Mourão, Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action. 1996, Pubmed , Echinobase
Mourão, Antithrombotic activity of a fucosylated chondroitin sulphate from echinoderm: sulphated fucose branches on the polysaccharide account for its antithrombotic action. 1998, Pubmed , Echinobase
Mourão, Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm. 2001, Pubmed , Echinobase
Muanza, Primary culture of human lung microvessel endothelial cells: a useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence. 1996, Pubmed
Munir, Heparin in the treatment of cerebral malaria. 1980, Pubmed
Newbold, Receptor-specific adhesion and clinical disease in Plasmodium falciparum. 1997, Pubmed
Noviyanti, Multiple var gene transcripts are expressed in Plasmodium falciparum infected erythrocytes selected for adhesion. 2001, Pubmed
Ockenhouse, Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor. 1989, Pubmed
Pacheco, Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm. 2000, Pubmed , Echinobase
Pouvelle, [Plasmodium falciparum and chondroitin-4-sulfate: the new key couple in sequestration]. 1998, Pubmed
Pouvelle, Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. 2000, Pubmed
Pouvelle, Chondroitin-4-sulfate impairs in vitro and in vivo cytoadherence of Plasmodium falciparum infected erythrocytes. 1997, Pubmed
Pouvelle, Modeling of Plasmodium falciparum-infected erythrocyte cytoadhesion in microvascular conditions: chondroitin-4-sulfate binding, A competitive phenotype. 2003, Pubmed
Rampengan, Cerebral malaria in children. Comparative study between heparin, dexamethasone and placebo. 1991, Pubmed
Ranjan, Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. 1999, Pubmed
Rieckmann, Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. 1978, Pubmed
Robert, Chondroitin-4-sulphate (proteoglycan), a receptor for Plasmodium falciparum-infected erythrocyte adherence on brain microvascular endothelial cells. 1995, Pubmed
Rogerson, Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. 1999, Pubmed
Rogerson, Sulfated glycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes. 1994, Pubmed
Rogerson, Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. 1995, Pubmed
Rowe, Plasmodium falciparum rosetting is associated with malaria severity in Kenya. 1995, Pubmed
Rowe, Plasmodium falciparum: a family of sulphated glycoconjugates disrupts erythrocyte rosettes. 1994, Pubmed
Salanti, Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. 2003, Pubmed
Sheehy, Complications of falciparum malaria and their treatment. 1967, Pubmed
Sivaraman, Effect of heparin sodium on in vitro development of Plasmodium falciparum. 1983, Pubmed
Smitskamp, New concepts in treatment of malignant tertian malaria with cerebral involvement. 1971, Pubmed
Snow, The global distribution of clinical episodes of Plasmodium falciparum malaria. 2005, Pubmed
Steketee, The burden of malaria in pregnancy in malaria-endemic areas. 2001, Pubmed
Suguitan, Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. 2003, Pubmed
Taylor, Differentiating the pathologies of cerebral malaria by postmortem parasite counts. 2004, Pubmed
Treutiger, Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. 1992, Pubmed
Turner, Severe malaria is associated with parasite binding to endothelial protein C receptor. 2013, Pubmed
Udomsangpetch, Plasmodium falciparum-infected erythrocytes form spontaneous erythrocyte rosettes. 1989, Pubmed
Valle-Delgado, Demonstration of specific binding of heparin to Plasmodium falciparum-infected vs. non-infected red blood cells by single-molecule force spectroscopy. 2013, Pubmed
Vieira, Structure of a fucose-branched chondroitin sulfate from sea cucumber. Evidence for the presence of 3-O-sulfo-beta-D-glucuronosyl residues. 1991, Pubmed , Echinobase
Vieira, Occurrence of a unique fucose-branched chondroitin sulfate in the body wall of a sea cucumber. 1988, Pubmed , Echinobase
Vogt, Release of sequestered malaria parasites upon injection of a glycosaminoglycan. 2006, Pubmed
Xiao, Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes. 1996, Pubmed
Zancan, Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans. 2004, Pubmed , Echinobase